Samia Aleem

My research focus includes large epidemiological database analyses to improve the health and outcomes of premature and critically ill infants. In particular, I am interested in neonatal infections, chronic lung disease, and improving the care and outcomes of infants with congenital diaphragmatic hernias.

Selected Grants

PTN 3.0 Task Order #2_ BPCA Pediatric Drug Development Clinical Trial Infrastructure

ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030

Duke-Utah HEAL KIDS Pain Resource and Data Center

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2030

NICHD Pediatric and Maternal Resource Center: Bridging Pharmacology and the Real World

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2028

BPCA Innovative Trial Designs and Assay Developments in Pediatric Therapeutics

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2027

HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network

ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2027

A Phase 2, Two-Stage, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS0071 in Newborns with Moderate or Severe Hypoxic-Ischemic Encepha

Clinical TrialPrincipal Investigator · Awarded by ReAlta Life Sciences, Inc. · 2023 - 2026

BPCA Data Closeout, Results Dissemination, And Stakeholder Engagement (Version 2.0)

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2025

Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2025

A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)

Clinical TrialPrincipal Investigator · Awarded by Airway Therapeutics · 2021 - 2025

A MULTICENTER, OPEN-LABEL, RANDOMIZED, ACTIVE COMPARATOR STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF LACOSAMIDE IN NEONATES WITH REPEATED ELECTROENCEPHALOGRAPHIC NEONATAL SEIZURES

Clinical TrialPrincipal Investigator · Awarded by UCB Biopharma SPRL · 2020 - 2024